WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 5 fonti

Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs

Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".

Raccontata dacnbc.comfortune.comft.comupi.combbc.com

Confronto fonti

5 prospettive sulla stessa storia
AI · summaries
bbc.comStai leggendo4 mesi fa

Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs

Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".

originale
cnbc.com4 mesi fa

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

Leggi questa versione → originale
upi.com4 mesi fa

Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the company announced Monday.

Leggi questa versione → originale
fortune.com4 mesi fa

Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments.

Leggi questa versione → originale
ft.com4 mesi fa

Novo Nordisk sues Hims & Hers over copycat weight-loss drugs

Shares in US company fall 16% after FDA announces investigation into unregulated medication

Leggi questa versione → originale

Timeline cronologica

  1. sabato 7 febbraio 2026·cnbc.com

    Hims & Hers pulls copycat weight-loss pill after threats of legal action

    Hims & Hers on Saturday announced it would stop offering its copycat of the weight-loss pill Wegovy after threats of legal action.

  2. sabato 7 febbraio 2026·fortune.com

    Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

    The announcement comes a day after the US Food and Drug Administration said it was cracking down on copycat weight-loss treatments.

  3. lunedì 9 febbraio 2026·cnbc.com

    Novo Nordisk pops 8% after Hims & Hers pulls copycat weight-loss pill

    Novo Nordisk shares jumped 8% Monday after Hims & Hers said it will pull its copycat weight-loss pill off the market.

  4. lunedì 9 febbraio 2026·cnbc.com

    Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

    Novo is asking the court to permanently ban Hims from selling compounded versions of its drugs that infringe patents, and is seeking to recover damages.

  5. lunedì 9 febbraio 2026·ft.com

    Novo Nordisk sues Hims & Hers over copycat weight-loss drugs

    Shares in US company fall 16% after FDA announces investigation into unregulated medication

  6. lunedì 9 febbraio 2026·upi.com

    Novo Nordisk suing Hims & Hers over ‘copycat’ weight loss drug - UPI.com

    Novo Nordisk, the maker of the weight loss drug Wegovy, is suing Hims & Hers for selling a cheaper version of the drug, the company announced Monday.

  7. martedì 10 febbraio 2026·bbc.com

    Wegovy maker Novo Nordisk sues rival over 'knock-off' weight-loss drugs

    Novo Nordisk says Hims & Hers' drugs breach its patent; Hims & Hers calls the lawsuit a "blatant attack".